Glutarate regulates T cell metabolism and anti-tumour immunity
© 2023. The Author(s)..
T cell function and fate can be influenced by several metabolites: in some cases, acting through enzymatic inhibition of α-ketoglutarate-dependent dioxygenases, in others, through post-translational modification of lysines in important targets. We show here that glutarate, a product of amino acid catabolism, has the capacity to do both, and has potent effects on T cell function and differentiation. We found that glutarate exerts those effects both through α-ketoglutarate-dependent dioxygenase inhibition, and through direct regulation of T cell metabolism via glutarylation of the pyruvate dehydrogenase E2 subunit. Administration of diethyl glutarate, a cell-permeable form of glutarate, alters CD8+ T cell differentiation and increases cytotoxicity against target cells. In vivo administration of the compound is correlated with increased levels of both peripheral and intratumoural cytotoxic CD8+ T cells. These results demonstrate that glutarate is an important regulator of T cell metabolism and differentiation with a potential role in the improvement of T cell immunotherapy.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:5 |
---|---|
Enthalten in: |
Nature metabolism - 5(2023), 10 vom: 22. Okt., Seite 1747-1764 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Minogue, Eleanor [VerfasserIn] |
---|
Links: |
---|
Themen: |
---|
Anmerkungen: |
Date Completed 26.10.2023 Date Revised 16.02.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1038/s42255-023-00855-2 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM36103637X |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM36103637X | ||
003 | DE-627 | ||
005 | 20240216232614.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1038/s42255-023-00855-2 |2 doi | |
028 | 5 | 2 | |a pubmed24n1295.xml |
035 | |a (DE-627)NLM36103637X | ||
035 | |a (NLM)37605057 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Minogue, Eleanor |e verfasserin |4 aut | |
245 | 1 | 0 | |a Glutarate regulates T cell metabolism and anti-tumour immunity |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 26.10.2023 | ||
500 | |a Date Revised 16.02.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2023. The Author(s). | ||
520 | |a T cell function and fate can be influenced by several metabolites: in some cases, acting through enzymatic inhibition of α-ketoglutarate-dependent dioxygenases, in others, through post-translational modification of lysines in important targets. We show here that glutarate, a product of amino acid catabolism, has the capacity to do both, and has potent effects on T cell function and differentiation. We found that glutarate exerts those effects both through α-ketoglutarate-dependent dioxygenase inhibition, and through direct regulation of T cell metabolism via glutarylation of the pyruvate dehydrogenase E2 subunit. Administration of diethyl glutarate, a cell-permeable form of glutarate, alters CD8+ T cell differentiation and increases cytotoxicity against target cells. In vivo administration of the compound is correlated with increased levels of both peripheral and intratumoural cytotoxic CD8+ T cells. These results demonstrate that glutarate is an important regulator of T cell metabolism and differentiation with a potential role in the improvement of T cell immunotherapy | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 7 | |a Glutarates |2 NLM | |
700 | 1 | |a Cunha, Pedro P |e verfasserin |4 aut | |
700 | 1 | |a Wadsworth, Brennan J |e verfasserin |4 aut | |
700 | 1 | |a Grice, Guinevere L |e verfasserin |4 aut | |
700 | 1 | |a Sah-Teli, Shiv K |e verfasserin |4 aut | |
700 | 1 | |a Hughes, Rob |e verfasserin |4 aut | |
700 | 1 | |a Bargiela, David |e verfasserin |4 aut | |
700 | 1 | |a Quaranta, Alessandro |e verfasserin |4 aut | |
700 | 1 | |a Zurita, Javier |e verfasserin |4 aut | |
700 | 1 | |a Antrobus, Robin |e verfasserin |4 aut | |
700 | 1 | |a Velica, Pedro |e verfasserin |4 aut | |
700 | 1 | |a Barbieri, Laura |e verfasserin |4 aut | |
700 | 1 | |a Wheelock, Craig E |e verfasserin |4 aut | |
700 | 1 | |a Koivunen, Peppi |e verfasserin |4 aut | |
700 | 1 | |a Nathan, James A |e verfasserin |4 aut | |
700 | 1 | |a Foskolou, Iosifina P |e verfasserin |4 aut | |
700 | 1 | |a Johnson, Randall S |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Nature metabolism |d 2019 |g 5(2023), 10 vom: 22. Okt., Seite 1747-1764 |w (DE-627)NLM295098996 |x 2522-5812 |7 nnns |
773 | 1 | 8 | |g volume:5 |g year:2023 |g number:10 |g day:22 |g month:10 |g pages:1747-1764 |
856 | 4 | 0 | |u http://dx.doi.org/10.1038/s42255-023-00855-2 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 5 |j 2023 |e 10 |b 22 |c 10 |h 1747-1764 |